Tenon Medical Income Statement (2021-2026) | TNON

Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.02M0.07M0.05M0.07M0.14M0.21M0.28M0.43M0.74M0.94M0.81M0.72M0.90M0.89M0.77M0.73M0.56M1.17M1.48M1.38M
Cost of Revenue (Quarter)
0.01M0.02M0.02M0.28M0.27M0.30M0.48M0.48M0.55M0.41M0.25M0.25M0.43M0.47M0.42M0.40M0.32M0.40M0.46M0.43M
Gross Profit (Quarter)
0.01M0.05M0.04M-0.20M-0.14M-0.09M-0.21M-0.05M0.19M0.54M0.56M0.47M0.47M0.42M0.35M0.32M0.24M0.77M1.02M0.94M
Operating items
Research & Development (Quarter)
0.24M0.60M1.22M0.28M1.94M0.65M4.60M2.03M0.90M1.53M-2.27M1.38M0.71M0.66M-1.44M1.65M1.12M0.43M4.40M1.86M
Selling, General & Administrative (Quarter)
0.48M0.99M1.14M1.04M2.72M1.73M1.94M1.98M1.73M1.65M1.67M1.93M2.19M1.76M1.89M1.66M1.48M2.20M1.63M1.71M
Other Operating Expenses (Quarter)
0.91M0.56M0.24M0.56M0.66M0.80M1.18M0.83M1.88M0.74M4.31M0.67M1.45M1.21M3.08M0.69M0.50M1.54M-2.15M0.66M
Operating Expenses (Quarter)
1.63M2.15M2.60M1.88M5.32M3.17M7.72M4.84M4.52M3.91M3.70M3.98M4.34M3.63M3.53M4.00M3.10M4.17M3.88M4.22M
Operating Income (Quarter)
-1.61M-2.10M-2.56M-2.08M-5.46M-3.26M-7.93M-4.89M-4.32M-3.38M-3.14M-3.51M-3.87M-3.21M-3.17M-3.68M-2.86M-3.39M-2.87M-3.28M
EBIT (Quarter)
-1.61M-2.10M-2.56M-2.08M-5.46M-3.26M-7.93M-4.89M-4.32M-3.38M-3.14M-3.51M-3.87M-3.21M-3.17M-3.68M-2.86M-3.39M-2.87M-3.28M
Non-operating items
Non Operating Investment Income (Quarter)
0.00M0.00M0.00M-0.03M0.07M0.07M0.06M0.04M0.05M0.02M0.03M0.04M0.03M0.09M0.06M0.09M0.05M0.03M0.03M
Interest & Investment Income (Quarter)
0.00M
Other Non Operating Income (Quarter)
-0.00M0.02M0.02M-0.06M-0.06M0.01M-0.04M
Non Operating Income (Quarter)
-0.06M-0.27M-0.28M-0.27M-0.03M0.09M0.02M0.06M0.04M0.05M0.01M-0.07M0.05M0.03M0.09M0.06M0.09M0.05M0.03M-0.20M
Net income details
EBT (Quarter)
-1.68M-2.36M-2.69M-2.35M-5.63M-3.42M-7.92M-4.96M-5.22M-3.69M-3.22M-3.58M-3.92M-3.25M-2.98M-7.28M-2.87M-3.62M-6.23M-6.88M
Profit After Tax (Quarter)
-1.68M-2.36M-2.84M-2.35M-5.54M-3.20M-7.84M-4.83M-4.27M-3.33M-3.08M-3.58M-3.83M-3.18M-3.13M-3.62M-2.77M-3.34M-2.83M-3.48M
Income from Non-Controlling Interests (Quarter)
-0.01M-0.02M-0.01M0.02M0.01M
Income from Continuing Operations (Quarter)
-1.68M-2.36M-2.69M-2.35M-5.63M-3.42M-7.92M-4.96M-5.22M-3.69M-3.22M-3.58M-3.92M-3.25M-2.98M-7.28M-2.87M-3.62M-6.23M-6.88M
Consolidated Net Income (Quarter)
-1.68M-2.36M-2.69M-2.35M-5.63M-3.42M-7.92M-4.96M-5.22M-3.69M-3.22M-3.58M-3.92M-3.25M-2.98M-7.28M-2.87M-3.62M-6.23M-6.88M
Income towards Parent Company (Quarter)
-1.68M-2.36M-2.69M-2.35M-5.63M-3.42M-7.92M-4.96M-5.22M-3.69M-3.22M-3.58M-3.92M-3.25M-2.98M-7.28M-2.87M-3.62M-6.23M-6.88M
Net Income towards Common Stockholders (Quarter)
-1.68M-2.36M-2.69M-2.35M-5.63M-3.42M-7.92M-4.96M-5.22M-3.69M-3.22M-3.58M-3.92M-3.25M-2.98M-7.28M-2.87M-3.62M-6.23M-6.88M
Additional items
EPS (Basic) (Quarter)
-0.17M-0.21M-0.24M-190.16-0.05M-0.02M-0.08M-0.04M-0.03M-0.01M-0.01M-0.01M-0.01M-0.00M-0.00M-0.00M-377.95-438.18-844.26-610.58
EPS (Diluted) (Quarter)
-0.17M-0.21M-0.24M-0.20M-0.05M-0.02M-0.08M-0.04M-0.03M-0.01M-0.01M-0.01M-0.01M-0.00M-0.00M-0.00M-377.95-438.18-844.26-610.58
Shares Outstanding (Quarter)
10.0011.0011.000.01M105.00140.00100.00141.00163.00284.00227.00357.00469.00877.000.00M0.00M0.01M0.01M0.01M0.01M
Shares Outstanding (Diluted) (Quarter)
10.0011.0011.0012.00105.00140.00100.00141.00163.00284.00227.00357.00469.00877.000.00M0.00M0.01M0.01M0.01M0.01M
Shares Outstanding (Entity) (Quarter)
105.00140.00100.00141.00163.00284.00227.00357.00469.00877.000.00M0.00M
EBITDA (Quarter)
-1.61M-2.10M-2.56M-2.08M-5.46M-3.26M-7.93M-4.89M-4.32M-3.38M-3.14M-3.51M-3.87M-3.21M-3.17M-3.68M-2.86M-3.39M-2.87M-3.28M
Interest Expenses (Quarter)
0.06M0.27M0.13M0.27M0.18M0.16M-0.01M0.07M0.91M0.31M0.07M0.07M0.05M0.04M-0.19M3.60M0.01M0.22M3.37M3.60M